Skip to main content
Log in

Substantial burden of C. difficile infection in the UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Tresman R, et al. Healthcare resource use and attributable cost of Clostridium difficile infection: a micro-costing analysis comparing first and recurrent episodes. Journal of Antimicrobial Chemotherapy : 2 Jul 2018. Available from: URL: http://doi.org/10.1093/jac/dky250

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Substantial burden of C. difficile infection in the UK. PharmacoEcon Outcomes News 808, 30 (2018). https://doi.org/10.1007/s40274-018-5145-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5145-2

Navigation